glutamic acid and ro13-9904

glutamic acid has been researched along with ro13-9904 in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	15 (22.73)	29.6817
2010's	43 (65.15)	24.3611
2020's	8 (12.12)	2.80

Authors

Authors	Studies
Böttcher, T; Bunkowski, S; Christen, S; Gerber, J; Goiny, M; Kuhnt, U; Lotz, M; Lykkesfeldt, J; Nau, R; Ren, H; Schau, I; Spreer, A; Werner, C	1
Cleveland, DW; Miller, TM	1
Secko, D	1
Brown, RH	1
Beghi, E; Bendotti, C; Mennini, T	1
Mineur, YS; Picciotto, MR; Sanacora, G	1
Chu, K; Jung, KH; Kim, EH; Kim, JM; Kim, M; Kim, SJ; Ko, SY; Lee, SK; Lee, ST; Park, DK; Roh, JK; Sinn, DI; Song, EC	1
Rothstein, JD; Sattler, R	1
Bai, JZ; Donnelly, D; Li, D; Lipski, J; Pi, R; Wan, CK	1
Giffard, RG; Ouyang, YB; Voloboueva, LA; Xu, LJ	1
Amin, M; Rawls, SM; Robinson, W; Tallarida, R	1
Barhwal, K; Hota, SK; Ilavazhagan, G; Ray, K; Singh, SB	1
Barton, SJ; Dorner, JL; Kennedy, RT; Miller, BR; Rebec, GV; Sari, Y; Sengelaub, DR; Shou, M	1
Funke-Kaiser, H; Godes, M; Hörtnagl, H; Krikov, M; Lucht, K; Müller, S; Namsolleck, P; Neumann, C; Rumschüssel, K; Schefe, JH; Schmerbach, K; Steckelings, UM; Thöne-Reineke, C; Unger, T; Villringer, A	1
Albrecht, P; Henke, N; Karumbayaram, S; Kornblum, HI; Lewerenz, J; Maher, P; Methner, A; Schubert, D; Tien, ML; Wiedau-Pazos, M	1
Kalivas, PW; Knackstedt, LA; Melendez, RI	1
Cai, J; Hu, Y; Li, L; Li, Q; Li, W; Lu, L; Xian, X; Zhang, M	1
Bero, AW; Holtzman, DM; Wong, M; Zeng, LH; Zhang, B	1
Baron, DA; Kim, JK; Rasmussen, BA; Rawls, SM; Unterwald, EM	1
Mishra, V; Raghubir, R; Sasmal, D; Verma, R	1
Crysdale, NY; Harrison, JA; Kroll, JL; Lewis, MT; Maier, SF; Morgan, KN; Ramos, KM; Sloane, EM; Taylor, FR; Watkins, LR	1
Bachetti, T; Balbi, P; Ceccherini, I; Sechi, G	1
Beller, JA; Berman, RF; Gurkoff, GG; Lyeth, BG	1
Chiu, TH; Huang, YT; Lai, CJ; Lai, PC; Wang, PJ; Wu, CC	1
Pan, XD; Wei, J; Xiao, GM	1
Carbone, M; Duty, S; Rattray, M	1
Kalivas, PW; Knackstedt, LA; LaLumiere, RT; Reissner, KJ; Trantham-Davidson, H	1
Guo, ZH; Jiao, H; Liu, CH; Peng, Y; Wang, WZ	1
De Michele, M; Mormile, R; Squarcia, U; Vittori, G	1
Alajaji, M; Bowers, MS; Damaj, MI; Knackstedt, L	1
Arnold, JC; Bondada, V; Chotibut, T; Davis, RW; Frenchek, Z; Geddes, JW; Gurwara, S; Salvatore, MF	1
Rao, PS; Sari, Y	1
Dong, Y; Feng, D; Gao, G; Huang, J; Ma, Y; Qin, H; Wang, W; Wu, L; Wu, S; Zhang, Z	1
Alhaddad, H; Das, SC; Sari, Y	1
Boger, H; Hensley, M; Kalivas, PW; Scofield, MD; Shen, HW	1
Gozal, E; Jagadapillai, R; Mellen, NM; Sachleben, LR	1
Qu, S; Zhang, X; Zhang, Y	1
Bianchi, E; Cerretani, D; Ghelardini, C; Menicacci, C	1
Hu, YY; Li, L; Li, WB; Wang, D; Xu, J; Zhang, M	1
Bhad, R; Hazari, N	1
Medrano, MC; Mendiguren, A; Pineda, J	1
Aliaga, A; Gauthier, S; Gratton, A; Leuzy, A; Moquin, L; Parent, MJ; Rosa-Neto, P; Schirrmacher, ES; Skelin, I; Soucy, JP; Zimmer, ER	1
Cheng, D; Hawkins, C; Kieu, Z; Kilian, J; Kitazawa, M; Lim, SL; Medeiros, R; Rodriguez-Ortiz, CJ; Wai, T; Zumkehr, J	1
Das, SC; Hristov, AM; Sari, Y; Yamamoto, BK	1
Kalivas, PW; Roberts-Wolfe, DJ	1
Chen, YL; Li, D; Li, RP; Wang, ZZ; Xu, WG; Zhang, JD	1
Hill, K; Knackstedt, LA; LaCrosse, AL	1
Bobadilla, AC; Bollati, F; Brown, RM; Cancela, LM; Esparza, MA; Garcia-Keller, C; Gipson, CD; Heinsbroek, JA; Kalivas, PW; Kupchik, YM; Roberts-Wolfe, DJ; Spencer, S	1
Almalki, AH; Alshehri, FS; Althobaiti, YS; Das, SC; Sari, Y	1
Hefendehl, JK; Ko, RW; LeDue, J; MacVicar, BA; Mahler, J; Murphy, TH	1
Gauthier, S; Hamel, E; Kim, HI; Lecrux, C; Leuzy, A; Parent, MJ; Pellerin, L; Rosa-Neto, P; Souza, DG; Zimmer, ER	1
Bajrektarevic, D; Nistri, A	1
Bjerrum, OJ; Gegelashvili, G; Heegaard, AM; Kristensen, PJ; Munro, G	1
Budziszewska, B; Bystrowska, B; Filip, M; Krzyżanowska, W; Pera, J; Pomierny, B; Pomierny-Chamioło, L	1
Behar, KL; Dienel, GA; Rothman, DL	1
Fan, S; Hu, Y; Li, L; Li, W; Xian, X; Yao, X; Zhang, M	1
Filip, M; Mizera, J; Niedzielska-Andres, E; Pomierny-Chamioło, L; Sadakierska-Chudy, A	1
Karyakin, VB; Malkin, SL; Postnikova, TY; Romanova, IV; Smolensky, IV; Zaitsev, AV; Zakharova, MV; Zavyalov, V; Zubareva, OE	1
Bie, B; Foss, JF; Naguib, M; Wu, J	1
Baggio, S; de Oliveira, DL; Dias, RD; Dos Santos, TG; Lazzarotto, G; Martins Silva, A; Mussulini, BH; Rech, G; Rico, EP; Zenki, K	1
Agostini, JF; Baldin, SL; Bernardo, HT; Costa, NLF; de Pieri Pickler, K; Manenti, MC; Mendes, NV; Rico, EP	1
Fierro, D; Filip, M; Knackstedt, LA; Mesa, J; Smaga, I	1
Fan, S; Gao, J; Li, L; Li, W; Liu, L; Xian, X	1
Malkin, SL; Postnikova, TY; Smolensky, IV; Zaitsev, AV; Zakharova, MV; Zubareva, OE	1
Cawley, NX; Cougnoux, A; Fellmeth, M; Navid, F; Porter, FD; Serra-Vinardell, J; Wassif, CA; Yerger, JC	1
Alasmari, F; Althobaiti, YS; Das, SC; Hammad, AM; Sari, Y	1

Reviews

2 review(s) available for glutamic acid and ro13-9904

Article	Year
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS & neurological disorders drug targets, 2015, Volume: 14, Issue:6 Topics: Acetylcysteine; Animals; Ceftriaxone; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Neurotransmitter Uptake Inhibitors; Substance-Related Disorders	2015
Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease. Neuroscience and biobehavioral reviews, 2020, Volume: 115 Topics: Amyloid beta-Peptides; Animals; Anti-Bacterial Agents; Ceftriaxone; Excitatory Amino Acid Transporter 2; Glutamic Acid; Rodentia; Substance-Related Disorders	2020

Other Studies

64 other study(ies) available for glutamic acid and ro13-9904

Article	Year
Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. Journal of neurochemistry, 2004, Volume: 91, Issue:6 Topics: Animals; Anti-Bacterial Agents; Body Temperature; Brain; Ceftriaxone; Cell Line, Tumor; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Clindamycin; Colony Count, Microbial; Glutamic Acid; Glycerol; Humans; Lactic Acid; Leukocyte Count; Lipid Peroxidation; Lipopolysaccharides; Male; Meningitis, Pneumococcal; Microdialysis; Neuroprotective Agents; Rabbits; Teichoic Acids; Tyrosine	2004
Medicine. Treating neurodegenerative diseases with antibiotics. Science (New York, N.Y.), 2005, Jan-21, Volume: 307, Issue:5708 Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; beta-Lactams; Brain; Ceftriaxone; Clinical Trials as Topic; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Mice; Motor Neurons; Neurodegenerative Diseases; Spinal Cord; Synapses; Synaptic Transmission	2005
Antibiotics that protect the brain. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Feb-15, Volume: 172, Issue:4 Topics: Amino Acid Transport System X-AG; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Mice; Neuroprotective Agents; Promoter Regions, Genetic; RNA, Messenger	2005
Amyotrophic lateral sclerosis--a new role for old drugs. The New England journal of medicine, 2005, Mar-31, Volume: 352, Issue:13 Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Glutamic Acid; Mice; Neuroprotective Agents	2005
Merits of a new drug trial for ALS? Science (New York, N.Y.), 2005, Apr-29, Volume: 308, Issue:5722 Topics: Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Biological Transport; Ceftriaxone; Clinical Trials as Topic; Glutamic Acid; Humans; Rats; Spinal Cord	2005
Antidepressant-like effects of ceftriaxone in male C57BL/6J mice. Biological psychiatry, 2007, Jan-15, Volume: 61, Issue:2 Topics: Animals; Antidepressive Agents; Arousal; Ceftriaxone; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Fear; Feeding Behavior; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Motivation; Motor Activity; Reaction Time; Stress, Psychological	2007
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke, 2007, Volume: 38, Issue:1 Topics: Animals; Anti-Bacterial Agents; Astrocytes; Brain; Brain Ischemia; Ceftriaxone; Cell Communication; Cytoprotection; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Neurons; Neuroprotective Agents; Neurotoxins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Treatment Outcome; Up-Regulation	2007
Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression. Biological psychiatry, 2007, Jan-15, Volume: 61, Issue:2 Topics: Amino Acid Transport System X-AG; Animals; Antidepressive Agents; Brain; Ceftriaxone; Depressive Disorder; Glutamic Acid; Humans; Mice; Neuroprotective Agents; Receptors, Glutamate; Treatment Outcome	2007
Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience, 2007, May-11, Volume: 146, Issue:2 Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Bacterial Agents; Aspartic Acid; Ceftriaxone; Cell Death; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Hypoxia; Membrane Potentials; Neurons; Neuroprotective Agents; Organ Culture Techniques; Patch-Clamp Techniques; Rats; Stroke; Time Factors	2007
Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, Apr-18, Volume: 27, Issue:16 Topics: Animals; Astrocytes; Ceftriaxone; Cell Survival; Excitatory Amino Acid Transporter 2; Glial Fibrillary Acidic Protein; Glutamic Acid; Hippocampus; Immunohistochemistry; Ischemic Attack, Transient; Male; Membrane Potentials; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley; Up-Regulation	2007
The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. British journal of pharmacology, 2007, Volume: 151, Issue:7 Topics: Analgesics, Opioid; Analysis of Variance; Animals; Anti-Bacterial Agents; Aspartic Acid; beta-Lactams; Body Temperature; Ceftriaxone; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fever; Glutamic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Rats; Rats, Sprague-Dawley; Riluzole; Time Factors	2007
Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia. Neurobiology of learning and memory, 2008, Volume: 89, Issue:4 Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Chromatin; Chronic Disease; Excitatory Amino Acid Transporter 2; Glutamic Acid; Glutathione; Hippocampus; Hypoxia, Brain; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Maze Learning; Memory; Memory Disorders; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Space Perception	2008
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience, 2008, Apr-22, Volume: 153, Issue:1 Topics: Animals; Ceftriaxone; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Glutamic Acid; Huntington Disease; Male; Maze Learning; Mice; Mice, Transgenic; Phenotype; Synaptic Transmission; Up-Regulation	2008
The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. Journal of hypertension, 2008, Volume: 26, Issue:12 Topics: Animals; Anti-Bacterial Agents; Body Temperature; Brain; Brain Infarction; Ceftriaxone; Cerebrovascular Disorders; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Interleukin-6; Male; Nerve Growth Factors; Rats; Rats, Wistar; Regional Blood Flow; RNA, Messenger; Stroke; Survival Rate	2008
Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. Journal of neurochemistry, 2009, Volume: 111, Issue:2 Topics: Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Animals; Anti-Bacterial Agents; Astrocytes; Ceftriaxone; Cell Line; Fibroblasts; Glutamic Acid; Glutathione; Hippocampus; Humans; In Vitro Techniques; Mice; Mice, Knockout; Motor Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Spinal Cord; Stem Cells; Superoxide Dismutase; Superoxide Dismutase-1	2009
Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biological psychiatry, 2010, Jan-01, Volume: 67, Issue:1 Topics: Analysis of Variance; Animals; Antioxidants; Ceftriaxone; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Cystine; Disease Models, Animal; Dopamine Uptake Inhibitors; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Self Administration; Time Factors; Tritium	2010
An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain, 2010, Volume: 148, Issue:2 Topics: Analgesics; Animals; Ceftriaxone; Chronic Disease; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Hyperalgesia; Male; Oligodeoxyribonucleotides, Antisense; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Sciatica; Spinal Cord; Time Factors; Tritium; Up-Regulation	2010
Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex. Neurobiology of disease, 2010, Volume: 37, Issue:3 Topics: Animals; Astrocytes; Ceftriaxone; Cell Death; Disease Models, Animal; Down-Regulation; Epilepsy; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Glial Fibrillary Acidic Protein; Glutamic Acid; Mice; Mice, Knockout; Survival Rate; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Up-Regulation	2010
β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino acids, 2011, Volume: 40, Issue:2 Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Down-Regulation; Excitatory Amino Acid Transporter 2; Extracellular Space; Glutamic Acid; Lactams; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time	2011
Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. European journal of pharmacology, 2010, Jul-25, Volume: 638, Issue:1-3 Topics: Animals; Brain; Brain Ischemia; Ceftriaxone; Cerebral Infarction; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamate-Ammonia Ligase; Glutamic Acid; Kainic Acid; Male; Neuroglia; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Up-Regulation	2010
Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience, 2010, Sep-15, Volume: 169, Issue:4 Topics: Animals; Ceftriaxone; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Pain, Intractable; Rats; Rats, Sprague-Dawley; Spinal Cord; Up-Regulation	2010
Correspondence regarding: Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. Journal of neuropathology and experimental neurology, 2010, Volume: 69, Issue:12 Topics: Alexander Disease; Amino Acid Transport System X-AG; Astrocytes; Ceftriaxone; Glial Fibrillary Acidic Protein; Glutamic Acid; Humans; Mutation	2010
Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro. Restorative neurology and neuroscience, 2011, Volume: 29, Issue:5 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Ceftriaxone; Cells, Cultured; Coculture Techniques; Excitatory Amino Acid Transporter 1; Glucose Transporter Type 1; Glutamic Acid; Nerve Degeneration; Neurotoxins; Proline; Rats; Rats, Sprague-Dawley; Up-Regulation	2011
Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats. Journal of biomedical science, 2011, Sep-21, Volume: 18 Topics: Animals; Animals, Newborn; Astrocytes; Blotting, Western; Ceftriaxone; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Hippocampus; Hypoxia-Ischemia, Brain; Immunohistochemistry; In Situ Nick-End Labeling; Neuropsychological Tests; Rats	2011
[Effects of β-lactam antibiotics ceftriaxone on expression of glutamate in hippocampus after traumatic brain injury in rats]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2011, Volume: 40, Issue:5 Topics: Animals; Brain Injuries; Ceftriaxone; Disease Models, Animal; Female; Glutamic Acid; Hippocampus; Male; Rats; Rats, Sprague-Dawley	2011
Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochemistry international, 2012, Volume: 60, Issue:1 Topics: Animals; Astrocytes; Ceftriaxone; Cells, Cultured; Excitatory Amino Acid Transporter 2; Glutamic Acid; Isoxazoles; Mice; Neostriatum; Neuroprotective Agents; Riluzole; Up-Regulation; Zonisamide	2012
Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Sep-05, Volume: 32, Issue:36 Topics: Animals; Ceftriaxone; Cocaine; Extinction, Psychological; Glutamic Acid; Male; Nucleus Accumbens; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Self Administration; Synaptic Transmission	2012
Up-regulated GLT-1 resists glutamate toxicity and attenuates glutamate-induced calcium loading in cultured neurocytes. Basic & clinical pharmacology & toxicology, 2013, Volume: 112, Issue:1 Topics: Animals; Calcium; Ceftriaxone; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Transporter 2; Glutamic Acid; Rats; Rats, Wistar; Up-Regulation	2013
Ceftriaxone-induced neuroprotection in glutamate excitotoxicity: one more reason to treat bacterial meningitis with it? The Pediatric infectious disease journal, 2012, Volume: 31, Issue:11 Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Glutamic Acid; Humans; Meningitis, Bacterial; Neuroprotective Agents	2012
Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice. Psychopharmacology, 2013, Volume: 228, Issue:3 Topics: Amino Acid Transport Systems; Animals; Anti-Bacterial Agents; Ceftriaxone; Conditioning, Psychological; Cysteine; Excitatory Amino Acid Transporter 2; Extinction, Psychological; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Nicotine; Reinforcement, Psychology; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder	2013
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. Molecular neurobiology, 2014, Volume: 49, Issue:3 Topics: Animals; Ceftriaxone; Corpus Striatum; Glutamic Acid; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase	2014
Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats. Journal of molecular neuroscience : MN, 2014, Volume: 54, Issue:1 Topics: Alcoholism; Amino Acid Transport Systems, Acidic; Animals; Brain; Ceftriaxone; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Rats; Up-Regulation	2014
Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway. Neuroscience, 2014, May-30, Volume: 268 Topics: Animals; Apoptosis; Astrocytes; Brain Injuries; Caspase 3; Ceftriaxone; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Hippocampus; Male; Neoplasm Proteins; Neurons; Neuroprotective Agents; NF-kappa B; Nucleocytoplasmic Transport Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage	2014
Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats. Psychopharmacology, 2014, Volume: 231, Issue:20 Topics: Alcohol Drinking; Alcoholism; Amino Acid Transport Systems, Acidic; Animals; Ceftriaxone; Ethanol; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Nucleus Accumbens; Prefrontal Cortex; Protein Isoforms; Rats; Up-Regulation	2014
Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Apr-16, Volume: 34, Issue:16 Topics: Animals; Aspartic Acid; Ceftriaxone; Conditioning, Operant; Disease Models, Animal; Down-Regulation; Drug-Seeking Behavior; Excitatory Postsynaptic Potentials; Glutamic Acid; Heroin; Heroin Dependence; In Vitro Techniques; Male; Morpholinos; Neurons; Nucleus Accumbens; Potassium; Rats; Rats, Sprague-Dawley; Secondary Prevention; Synapses	2014
Ceftriaxone preserves glutamate transporters and prevents intermittent hypoxia-induced vulnerability to brain excitotoxic injury. PloS one, 2014, Volume: 9, Issue:7 Topics: Amino Acid Transport System X-AG; Animals; Ceftriaxone; Cell Hypoxia; Cell Survival; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; In Vitro Techniques; Rats; Rats, Sprague-Dawley	2014
Ceftriaxone Protects Astrocytes from MPP(+) via Suppression of NF-κB/JNK/c-Jun Signaling. Molecular neurobiology, 2015, Volume: 52, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Animals; Aspartic Acid; Astrocytes; Ceftriaxone; Cell Death; Cell Survival; Cells, Cultured; Glutamic Acid; Kinetics; MAP Kinase Signaling System; Neuroprotection; Neuroprotective Agents; NF-kappa B; Proto-Oncogene Proteins c-jun; Rats, Sprague-Dawley; Up-Regulation	2015
Spinal administration of mGluR5 antagonist prevents the onset of bortezomib induced neuropathic pain in rat. Neuropharmacology, 2014, Volume: 86 Topics: Analgesics; Animals; Boronic Acids; Bortezomib; Ceftriaxone; Cell Line, Tumor; Cell Survival; Central Nervous System Agents; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Hyperalgesia; Injections, Spinal; Male; Neural Conduction; Neuralgia; Peripheral Nervous System Diseases; Pyrazines; Pyridines; Random Allocation; Rats; Receptor, Metabotropic Glutamate 5	2014
Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats. Journal of neurochemistry, 2015, Volume: 132, Issue:2 Topics: Animals; Biological Transport; Brain Ischemia; CA1 Region, Hippocampal; Ceftriaxone; Drug Evaluation, Preclinical; Excitatory Amino Acid Transporter 2; Gene Knockdown Techniques; Glutamic Acid; Kainic Acid; Male; Neuroprotective Agents; Oligodeoxyribonucleotides, Antisense; Pyramidal Cells; Random Allocation; Rats; Rats, Wistar; Up-Regulation	2015
Potential dual role of cephalosporins in management of alcohol use disorders. Psychopharmacology, 2014, Volume: 231, Issue:24 Topics: Alcohol Drinking; Amino Acid Transport Systems, Acidic; Animals; Ceftriaxone; Ethanol; Glutamic Acid; Male; Nucleus Accumbens; Prefrontal Cortex	2014
Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Psychopharmacology, 2015, Volume: 232, Issue:15 Topics: Analgesics, Opioid; Animals; Ceftriaxone; Fructose; Glutamic Acid; Locus Coeruleus; Male; Morphine Dependence; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Substance Withdrawal Syndrome; Topiramate	2015
Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:7 Topics: Animals; Carbon Radioisotopes; Ceftriaxone; Excitatory Amino Acid Transporter 2; Glutamic Acid; Oximes; Positron-Emission Tomography; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Thalamus	2015
Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease. Neurobiology of aging, 2015, Volume: 36, Issue:7 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Brain; Ceftriaxone; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Mice, Inbred C57BL; Mice, Transgenic; Neurons; tau Proteins; Up-Regulation	2015
Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Neuropharmacology, 2015, Volume: 97 Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Ceftriaxone; Central Nervous System Depressants; Disease Models, Animal; Ethanol; Excitatory Amino Acid Transporter 2; Extracellular Space; Glutamate-Ammonia Ligase; Glutamic Acid; Kainic Acid; Male; Microdialysis; Nucleus Accumbens; Rats	2015
Glutamate metabolism of astrocytes during hyperbaric oxygen exposure and its effects on central nervous system oxygen toxicity. Neuroreport, 2016, Jan-20, Volume: 27, Issue:2 Topics: Air Pressure; Animals; Astrocytes; Brain; Ceftriaxone; Excitatory Amino Acid Transporter 2; Glutamate-Ammonia Ligase; Glutamic Acid; Kainic Acid; Male; Oxygen; Rats; Rats, Sprague-Dawley	2016
Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:2 Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Area Under Curve; Ceftriaxone; Chromatography, High Pressure Liquid; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Self Administration; Time Factors	2016
Glutamatergic mechanisms of comorbidity between acute stress and cocaine self-administration. Molecular psychiatry, 2016, Volume: 21, Issue:8 Topics: Animals; Ceftriaxone; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Comorbidity; Dendritic Spines; Excitatory Amino Acid Agents; Extinction, Psychological; Glutamic Acid; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Self Administration; Stress, Psychological; Synapses	2016
Effects of repeated high-dose methamphetamine and ceftriaxone post-treatments on tissue content of dopamine and serotonin as well as glutamate and glutamine. Neuroscience letters, 2016, Nov-10, Volume: 634 Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Central Nervous System Stimulants; Dopamine; Glutamic Acid; Glutamine; Male; Methamphetamine; Nucleus Accumbens; Organ Specificity; Prefrontal Cortex; Rats, Wistar; Serotonin	2016
Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging. Nature communications, 2016, 11-11, Volume: 7 Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Ceftriaxone; Diagnostic Imaging; Glutamic Acid; Mice; Mice, Transgenic; Plaque, Amyloid	2016
[ Nature neuroscience, 2017, Volume: 20, Issue:3 Topics: Animals; Astrocytes; Biological Transport; Brain; Ceftriaxone; Cells, Cultured; Excitatory Amino Acid Transporter 1; Fluorodeoxyglucose F18; Functional Neuroimaging; Glutamic Acid; Locomotion; Male; Positron-Emission Tomography; Rats; Vibrissae	2017
Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures. Neurotoxicology, 2017, Volume: 60 Topics: Animals; Anti-Bacterial Agents; Aspartic Acid; Astrocytes; Ceftriaxone; Excitatory Amino Acid Agonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Kainic Acid; Motor Neurons; Neurons; Neuroprotective Agents; Organ Culture Techniques; Rats, Wistar; Spinal Cord; Up-Regulation	2017
The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain. European journal of pain (London, England), 2018, Volume: 22, Issue:2 Topics: Analgesics; Animals; Astrocytes; Ceftriaxone; Cells, Cultured; Clavulanic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Male; Neuralgia; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Cord; Up-Regulation	2018
Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia. PloS one, 2017, Volume: 12, Issue:10 Topics: Acetylcysteine; Amino Acid Transport Systems, Acidic; Animals; Astrocytes; Brain Ischemia; Ceftriaxone; Excitatory Amino Acid Transporter 2; Frontal Lobe; Gene Expression Regulation; Glutamic Acid; Hippocampus; Humans; Infarction, Middle Cerebral Artery; Rats; Synaptic Transmission	2017
Cellular Origin of [ The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2018, Volume: 24, Issue:4 Topics: Animals; Astrocytes; Brain; Ceftriaxone; Central Nervous System Agents; Fluorodeoxyglucose F18; Glutamic Acid; Humans; Neurons; Positron-Emission Tomography; Radiopharmaceuticals	2018
Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice. Journal of Alzheimer's disease : JAD, 2018, Volume: 66, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Bacterial Agents; Ceftriaxone; Cognition; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Glutamine; Hippocampus; Maze Learning; Mice; Mice, Transgenic; Presenilin-1; Up-Regulation	2018
Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone. Behavioural brain research, 2019, 09-16, Volume: 370 Topics: Amino Acid Transport Systems, Acidic; Animals; Biomarkers, Pharmacological; Brain; Ceftriaxone; Cocaine; Cocaine-Related Disorders; Drug-Seeking Behavior; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Male; NF-E2-Related Factor 2; NF-kappa B; Nucleus Accumbens; Rats; Rats, Wistar; Reward; Self Administration	2019
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats. International journal of molecular sciences, 2019, Nov-21, Volume: 20, Issue:23 Topics: Animals; Anticonvulsants; Ceftriaxone; Epilepsy; Excitatory Amino Acid Transporter 2; Excitatory Postsynaptic Potentials; Gene Expression; Glutamic Acid; Hippocampus; Male; Rats, Wistar; Seizures; Synaptic Transmission; Temporal Lobe	2019
Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses. Molecular neurobiology, 2020, Volume: 57, Issue:5 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspartic Acid; Astrocytes; CA1 Region, Hippocampal; Ceftriaxone; Cognition Disorders; Complement C1q; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Male; Microglia; Morris Water Maze Test; Neurons; Patch-Clamp Techniques; Peptide Fragments; Phagocytosis; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Synapses; Up-Regulation	2020
Fetal alcohol spectrum disorders model alters the functionality of glutamatergic neurotransmission in adult zebrafish. Neurotoxicology, 2020, Volume: 78 Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Glutamate-Ammonia Ligase; Glutamic Acid; Male; Mitochondria; Sodium-Potassium-Exchanging ATPase; Synaptic Transmission; Vesicular Glutamate Transport Protein 2; Zebrafish	2020
Ceftriaxone Attenuated Anxiety-Like Behavior and Enhanced Brain Glutamate Transport in Zebrafish Subjected to Alcohol Withdrawal. Neurochemical research, 2020, Volume: 45, Issue:7 Topics: Alcohol Drinking; Animals; Anxiety; Brain; Ceftriaxone; Ethanol; Glutamic Acid; Oxidative Stress; Substance Withdrawal Syndrome; Zebrafish	2020
Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice. Neurobiology of learning and memory, 2021, Volume: 183 Topics: Alzheimer Disease; Amino Acid Transport System A; Amyloid beta-Protein Precursor; Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Mice; Mice, Transgenic; Presenilin-1; Presynaptic Terminals; Synaptic Vesicles; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2	2021
Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats. International journal of molecular sciences, 2021, Aug-05, Volume: 22, Issue:16 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Ceftriaxone; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Long-Term Potentiation; Male; Neuronal Plasticity; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission	2021
Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1. Molecular genetics and metabolism, 2021, Volume: 134, Issue:4 Topics: Animals; Astrocytes; Ceftriaxone; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Female; Glutamic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Riluzole	2021
Role of suppressing GLT-1 and xCT in ceftriaxone-induced attenuation of relapse-like alcohol drinking in alcohol-preferring rats. Addiction biology, 2022, Volume: 27, Issue:4 Topics: Alcohol Drinking; Alcoholism; Amino Acid Transport Systems, Acidic; Animals; Ceftriaxone; Ethanol; Excitatory Amino Acid Transporter 2; Glutamic Acid; Nucleus Accumbens; Rats; Recurrence	2022